Main > ONCOLOGY (**) > Prostate Cancer NON-MET CR *** > Treatment > DE. B. Darolutamide Tablets



DE. B. Darolutamide Tablets's subsections
(*) USA Approval Date: 2019. 07.30.
Company
Mechanism: Non-Steroid Androgen>
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2019. 11.12
TradeMark
TradeMark Web-Site

DE. B. Darolutamide Tablets's products
This section has no products